FRESEN.MED.CARE KGAA O.N.FF

FRESEN.MED.CARE KGAA O.N.

50.18EURD
−0.08−0.16%
As of today at 06:15 GMT
EUR
No trades
See on Supercharts

Price target

50.85DEUR+0.67+1.34%
The 19 analysts offering 1 year price forecasts for FRESEN.MED.CARE KGAA O.N. have a max estimate of 62.00 and a min estimate of 40.000.

Analyst rating

Based on 22 analysts giving stock ratings to FRESEN.MED.CARE KGAA O.N. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
6
Buy
1
Hold
10
Sell
2
Strong sell
3

EPS

Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Reported
Estimate
Currency: EUR
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪0.57‬
‪0.88‬
‪0.67‬
‪0.70‬
‪0.82‬
‪0.91‬
‪0.84‬
Estimate
‪0.54‬
‪0.83‬
‪0.55‬
‪0.68‬
‪0.71‬
‪0.80‬
‪0.75‬
‪0.86‬
‪1.00‬
‪1.14‬
Surprise
+5.06%
+5.49%
+22.25%
+2.98%
+15.40%
+13.94%
+11.80%

Revenue

Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
‪‪1.30 B‬‬
‪‪2.60 B‬‬
‪‪3.90 B‬‬
‪‪5.20 B‬‬
Reported
Estimate
Currency: EUR
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪‪4.94 B‬‬
‪‪4.99 B‬‬
‪‪4.72 B‬‬
‪‪4.74 B‬‬
‪‪4.82 B‬‬
‪‪5.07 B‬‬
‪‪4.88 B‬‬
Estimate
‪‪4.90 B‬‬
‪‪4.96 B‬‬
‪‪4.62 B‬‬
‪‪4.97 B‬‬
‪‪4.95 B‬‬
‪‪4.75 B‬‬
‪‪4.72 B‬‬
‪‪5.00 B‬‬
‪‪5.02 B‬‬
‪‪4.87 B‬‬
Surprise
+0.82%
+0.48%
+2.33%
−4.63%
−2.71%
+6.61%
+3.49%
Be warned

Frequently Asked Questions


FME EPS for the last quarter is 0.84 EUR despite the estimation of 0.75 EUR. In the next quarter EPS is expected to reach 0.86 EUR. Track more of FRESEN.MED.CARE KGAA O.N. financials and stay on top of what is up with the company.
In the next quarter FRESEN.MED.CARE KGAA O.N. revenue is expected to reach ‪5.00 B‬ EUR. Check out FRESEN.MED.CARE KGAA O.N. revenue and earnings and make informed decisions.
According to analysts, FME price target is 50.85 EUR with a max estimate of 62.00 EUR and a min estimate of 40.00 EUR. Check if this forecast comes true in a year, meanwhile watch FRESEN.MED.CARE KGAA O.N. stock price chart and keep track of the current situation with FME news and stock market news.
We've gathered opinions of 22 analysts rating FME stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.